NCT03339349View on ClinicalTrials.gov

Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

October 29, 2019

Conditions
Venous ThromboembolismDeep Vein ThrombosisPulmonary Embolus
Interventions
DRUG

Enoxaparin

Enrolled patients will receive real-time monitoring of peak and trough steady state anti-Xa levels. Out-of-range patients will receive real time dose adjustment of Enoxaparin using a clinical protocol developed with our inpatient pharmacists.

Trial Locations (1)

84112

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT03339349 - Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma | Biotech Hunter | Biotech Hunter